We are live on !
Find out more
Tonix Pharmaceuticals
TNXP
TNXP
hedge funds and large institutions have $37.1M invested in Tonix Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
6.67% less ownership
Funds ownership: 31.07% → 24.4% (-6.7%)
89% less call options, than puts
Call options by funds: $161K | Put options by funds: $1.46M
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $3.84M
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$161K
Puts
$1.46M
Net Calls
-$1.3M
Net Calls Change
-$1.3M
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deerfield Management
New York
|
-$2.54M |
| 2 |
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.04M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$240K |
| 4 |
B. Riley Wealth Management
Memphis,
Tennessee
|
-$10K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$7K |